PAO Grand Rounds: Orbital & Ocular Inflammation Secondary to Immunotherapy Medications

The Pennsylvania Academy of Ophthalmology

Presents

PAO Grand Rounds Series:  

Keeping an Eye on Ocular Adverse Events with Immunotherapy

and Targeted Cancer Drugs

Thursday, October 2, 2025, 7:30 PM

Faculty Speaker

Meghan Berkenstock, MD, 

Meghan Berkenstock, M.D., is an associate professor of ophthalmology at the Johns Hopkins Wilmer Eye Institute. She specializes in ocular inflammatory and infectious diseases, cataract surgery, and comprehensive ophthalmology. 

Since joining the faculty of the Wilmer Eye Institute in 2016, she has established a research focus on risk reduction and quality assurance initiatives in the care of patients with uveitis. She has implemented several initiatives to improve laboratory monitoring and understanding barriers to care in patients on immunosuppressive medications. The bulk of her research focuses on identifying ocular adverse events (IRAE) associated with the use of immunotherapy agents in the treatment of systemic malignancies. She is a member and the only ophthalmologist on the National Comprehensive Cancer Network Panel on developing guidelines to treat IRAEs.

1.00 AMA PRA Category 1 CME credit.

This free CME event is open to all ophthalmologists